THREAD Enriches Its Platform with CureClick to Accelerate Enrollment, Improve Diversity and Enhance the Patient Experience in Decentralized Clinical Trials
CARY, N.C., April 19, 2022 /PRNewswire/ -- THREAD®, a leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), today announced that it has acquired CureClick. Headquartered in Costa Mesa, Calif., CureClick offers the world's first proprietary crowdsourcing platform designed exclusively to accelerate awareness and participation in clinical research. CureClick follows THREAD's recent acquisitions of Modus Outcomes and inVibe, positioning THREAD as the industry's leading patient-centric provider of DCTs.
CureClick increases clinical trial awareness, and accelerates patient recruitment by enabling influential members of online communities to easily find, and disseminate accurate, patient-friendly information with their social networks.
Creating waves in the clinical trial marketplace.
We know patients see their online communities as lifelines, as one-stop-shops for the latest news, and information about their health conditions. We want to engage with them on their terms by partnering with the community leaders, and advocates they trust.